Two Different Brain Injuries, One Critical Need: Supporting Neuroplasticity After Encephalitis and Stroke
1. The key difference between both conditions
🧠 Encephalitis (e.g.
Nipah virus–related)
Nature
·
Acute brain inflammation, usually due to viral
infection
·
Rapid onset, high mortality, no definitive cure
or vaccine (for Nipah)
Main damage mechanism
·
Cytokine storm & neuroinflammation
·
Neuronal death
·
Suppression of neurotrophic factors (including
BDNF)
·
Severe oxidative stress
Clinical reality
·
Treatment = supportive care only
·
Goal = survive acute phase, limit damage
·
Long-term cognitive & psychosocial
impairment common
🧠 Chronic Stroke
(Post-acute / recovery phase)
Nature
·
Ischemic or hemorrhagic injury already occurred
·
Damage is localized, not infectious
·
Patient survives but with neurological deficits
Main damage mechanism
·
Neuronal loss due to hypoxia
·
Reduced neuroplasticity
·
Impaired synaptic reconnection
·
Chronic inflammation & oxidative stress
Clinical reality
·
No drug can regenerate brain tissue
·
Focus = rehabilitation, neuroplasticity, quality
of life
🔑 Core difference (simple
table)
|
Aspect |
Encephalitis |
Chronic
Stroke |
|
Phase |
Acute,
life-threatening |
Chronic,
recovery |
|
Cause |
Infection / inflammation |
Vascular
injury |
|
Inflammation |
Severe &
systematic |
Low-grade,
persistent |
|
Treatment |
Supportive
only |
Rehab & symptom |
|
Ummet need |
Neuroprotective
|
Neurodegeneration
|
2. Where PHYSTA® Tongkat Ali fits
(supportive role)
PHYSTA is NOT a treatment or cure for encephalitis or
stroke.
Its value is systemic support.
What PHYSTA can reasonably support:
·
✔️ Energy metabolism (ATP
support)
·
✔️ Stress modulation (↓ cortisol)
·
✔️ Immune resilience
·
✔️ Muscle strength & recovery
(important in post-stroke rehab)
·
✔️ Hormonal balance → indirectly
supports brain recovery
Why this matters in BOTH conditions:
·
Encephalitis survivors → extreme fatigue,
hormonal dysregulation
·
Stroke patients → muscle wasting, low endurance,
poor rehab tolerance
PHYSTA supports the body so the brain has a better
environment to recover.
3. KESUM ( Persicaria minor / Polygonum minus )
becomes the key differentiator
Mechanisms relevant to BOTH conditions
🔬 1. BDNF modulation
·
BDNF is critical for
·
Neuron survival
·
Synaptic plasticity
·
Cognitive recovery
Both encephalitis & stroke are associated with reduced
BDNF
👉 KESUM’s quercetin-rich
profile supports neurotrophic pathways
(supportive, not therapeutic claim)
🔬 2. Anti-inflammatory
(neuro-safe)
·
Helps down-regulate neuroinflammation
Relevant to:
·
Acute inflammatory damage (encephalitis recovery
phase)
·
Chronic micro-inflammation (post-stroke brain)
🔬 3. Antioxidant
neuroprotection
·
Reduces oxidative stress
·
Protects remaining neurons from secondary injury
Why KESUM is more relevant to the BRAIN than PHYSTA
|
Aspect |
PHYSTA |
KESUM |
|
Primary
action |
Systemic /
endocrine |
Neurocentric |
|
BDNF relevance |
Indirect |
Direct support |
|
Brain inflammation
|
Indirect |
Direct |
|
Cognitive
recovery |
Supportive |
Targeted
support |
4. ✅ PHYSTA supports systemic
strength, immune resilience & recovery capacity, while KESUM supports brain
neuroplasticity, inflammation balance & cognitive resilience. Together,
they create a supportive internal environment for neurological recovery - without
replacing medical care.
5. Encephalitis destroys the
brain through inflammation; stroke damages it through ischemia - but both
converge on one unmet need: restoring neuroplasticity. KESUM addresses the
brain, PHYSTA supports the body.
https://shop.biotropicsmalaysia.com/nu-prep-lelaki-90s-bm.html
KESUM
https://shop.biotropicsmalaysia.com/biotropics-en/biotropics-kesum-extract-250mg-bm.html
.jpeg)
.jpeg)
.jpeg)

.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)